Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model

SALL4 is a robust stimulator for the expansion of hematopoietic stem cells

(2011) J. R. Aguila et al.   BLOOD

Endothelial progenitor cell biology in disease and tissue regeneration

(2011) Andrea L George et al.   Journal of Hematology & Oncology

Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4

(2011) Jianchang Yang et al.   Journal of Hematology & Oncology

SALL4: finally an answer to the problem of expansion of hematopoietic stem cells?

(2011) Jerell R Aguila et al.   Expert Review of Hematology

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

(2009) RuiRong Yuan et al.   Journal of Hematology & Oncology

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

(2009) Dan Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SALL4 is a key regulator of survival and apoptosis in human leukemic cells

(2008) J. Yang et al.   BLOOD

Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro

(2008) A. Stahl et al.   FEBS LETTERS

Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells

(2008) J. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Generation of human induced pluripotent stem cells from dermal fibroblasts

(2008) W. E. Lowry et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA